On Monday, a person was admitted to Haukeland University Hospital with a blood clot after being vaccinated with AstraZeneca’s corona vaccine.
The hospital writes in a press release.
– A previously healthy person, who received the vaccine a couple of weeks ago, was admitted with a blood clot in his lungs on Monday, says director Marta Ebbing to Dagbladet, and adds:
– We follow the person closely, and report this as a possible vaccine side effect to the Norwegian Medicines Agency.
The person in question is a health personnel, but is not employed by Helse Bergen. At present, the director of the department cannot provide further information about the patient’s condition.
More hospitalized
On Saturday, it became known that three health workers had been admitted to Oslo University Hospital with a blood clot after receiving the AstraZeneca vaccine.
Sara Watle, chief physician at the National Institute of Public Health (NIPH), told Dagbladet that the three patients all had a serious illness.
– They are all under 50 years old, and have a disease picture that is very serious, with three different things. They have blood clots, bleeding and low platelets.
–
All subjects developed symptoms ten days after vaccination.
In Norway, 130,000 people have received a dose of the AstraZeneca vaccine. The serious side effects are very rare, but still something they take very seriously, Watle pointed out.
During a press conference on Monday afternoon, medical director, Steinar Madsen, confirmed that one of the hospitalized patients had died.
He was under 50 years old.
The patient, who was admitted to hospital a week after vaccination, appeared to be “approximately healthy” from before.
– Unfortunately, she had such a big event in her brain, so life could not be saved. She died yesterday. She received all the intensive care we could give at Rikshospitalet, said chief physician at the intensive care unit at Oslo University Hospital, Trine Kåsine.
The Norwegian Medicines Agency is investigating whether the symptoms and death are related to the vaccine.